Baidu
map

120天严打医药商业贿赂 开始了

2019-08-09 赛柏蓝—玉米 国家市场总局

严查医药商业贿赂4个月,开始了。▍市场总局:8月至12月严查医药商业贿赂日前,国家市场总局发通知,自8月至12月在全国范围内开展重点领域反不正当竞争执法行动,组织全国市场监管部门开展此次专项执法行动。国家市场总局指出,此次执法行动突出重点行业、重点领域,严查“保健”市场、互联网、医药等领域的仿冒混淆、商业贿赂、虚假宣传、商业诋毁等不正当竞争行为。此次专项执法行动,国家市场总局要查办一批具有典型意义

严查医药商业贿赂4个月,开始了。

▍市场总局:8月至12月严查医药商业贿赂

日前,国家市场总局发通知,自8月至12月在全国范围内开展重点领域反不正当竞争执法行动,组织全国市场监管部门开展此次专项执法行动。



国家市场总局指出,此次执法行动突出重点行业、重点领域,严查“保健”市场、互联网、医药等领域的仿冒混淆、商业贿赂、虚假宣传、商业诋毁等不正当竞争行为。

此次专项执法行动,国家市场总局要查办一批具有典型意义、严重影响竞争秩序、侵害经营者消费者合法权益的不正当竞争案件。

▍9部门全国查偷逃税,严打商业贿赂、洗钱

种种迹象表明,下半年对于医药行业领域商业贿赂的严查、打击开始了。其中,以9部分联合发布的文件释放的信号最明显。

8 月2日,由国家卫健委、国家医保局等9部门联合发布的《关于印发2019年纠正医药购销领域和医疗服务中不正之风工作要点的通知》在部分医院官网挂出。

9 部门发出最强音:严惩供销链条违法犯罪。加大对药品、耗材生产经营单位、医疗机构发票开具、使用等情况的检查处理,严查虚开发票、偷逃税等违法行为,严厉打击商业贿赂、洗钱等违法犯罪,维护行业秩序。

同时开展“一案多查",完善纠风联合惩戒“黑名单"制度,实现 “一处违规,处处受限”。

▍一批医药人要被抓典型

随着专项执法行动的开展,一批医药人要被抓典型。

对于行业来说,打击医药商业贿赂已经成为常态,从公布的案例看,医疗系统和医药行业被查的发生频率比较高。可以说,医药人对此已经略感麻木,也存在侥幸心理。

但是,此次专项行动的开展,是一定要有结果呈现作为行动的成果,所以,很大概率会有一批医药人被当做医药商业贿赂的典型被查获、法办。在接下来的4个月里,看到这个信号的医药人应当小心行事了。

▍行业需要正当竞争

实际上,医药人应当看到严打医药商业贿赂的正面意义。

正如国家市场总局此次行动的主旨——反不正当竞争,医药商业贿赂就是不正当竞争。

一定程度上,一些药企通过回扣营销的手段,将质量和疗效并不好的产品占据市场,那些真正的好药却生存艰难,所谓劣币驱逐良币正是商业贿赂的最大恶果之一。

假以时日,行业的商业贿赂渐渐消亡后,就会呈现出合理、公平的竞争环境,医药人凭借产品质量和服务等赢得市场,最终行业良性发展生机勃勃。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771798, encodeId=99e11e71798e7, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Tue Sep 24 18:47:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006629, encodeId=1e0c2006629cb, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Thu Mar 05 11:47:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409874, encodeId=e0af14098e454, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535076, encodeId=92a715350e60d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771798, encodeId=99e11e71798e7, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Tue Sep 24 18:47:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006629, encodeId=1e0c2006629cb, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Thu Mar 05 11:47:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409874, encodeId=e0af14098e454, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535076, encodeId=92a715350e60d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771798, encodeId=99e11e71798e7, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Tue Sep 24 18:47:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006629, encodeId=1e0c2006629cb, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Thu Mar 05 11:47:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409874, encodeId=e0af14098e454, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535076, encodeId=92a715350e60d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=)]
    2019-08-11 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771798, encodeId=99e11e71798e7, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Tue Sep 24 18:47:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006629, encodeId=1e0c2006629cb, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Thu Mar 05 11:47:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409874, encodeId=e0af14098e454, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535076, encodeId=92a715350e60d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun Aug 11 06:47:00 CST 2019, time=2019-08-11, status=1, ipAttribution=)]

相关资讯

严打商业贿赂!天津各大医院约谈药商

一场整治医药代表和商业贿赂的风暴正在天津迅速掀起。

首次发布!耗材商业贿赂被重创

A股上市医械公司,首份反舞弊制度文件公布,将从内部治理行贿受贿、玩忽职守。

Baidu
map
Baidu
map
Baidu
map